Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

NHL35700

Generic Name: NHL35700

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State

Phase 1

Completed

Posted: 2018/09/13

Sponsor:H. Lundbeck A/S

ID:NCT03670082

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

Phase 1

Terminated

Posted: 2017/08/07

Sponsor:H. Lundbeck A/S

ID:NCT03241147

Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia

Phase 3

Terminated

Posted: 2017/07/27

Sponsor:H. Lundbeck A/S

ID:NCT03230864

Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes

Phase 1

Completed

Posted: 2017/06/22

Sponsor:H. Lundbeck A/S

ID:NCT03195946

Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects

Phase 1

Completed

Posted: 2017/06/16

Sponsor:H. Lundbeck A/S

ID:NCT03189615

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy